Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low HDL”

93 trials

Showing 20 of 93 results

Testing effectiveness (Phase 2)Study completedNCT00749788
What this trial is testing

Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C Levels

Who this might be right for
Dyslipidemia
Akros Pharma Inc. 150
Not applicableStudy completedNCT01483950
What this trial is testing

Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target Values

Who this might be right for
Hypercholesterolaemia
AstraZeneca 800
Not applicableStudy completedNCT02233088
What this trial is testing

A Pilot Study of a Lifestyle Intervention on the Metabolic Syndrome (3ELM Study)

Who this might be right for
Metabolic Syndrome
Rush University Medical Center 48
Post-approval studies (Phase 4)Study completedNCT00819403
What this trial is testing

Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment

Who this might be right for
Metabolic Syndrome
University of Maryland, Baltimore 15
Large-scale testing (Phase 3)Study completedNCT01860729
What this trial is testing

The Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022)

Who this might be right for
Hypercholesterolemia
Merck Sharp & Dohme LLC 589
Large-scale testing (Phase 3)Study completedNCT00283335
What this trial is testing

The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-Cholesterol

Who this might be right for
Coronary Heart Disease
VA Office of Research and Development 2,531
Testing effectiveness (Phase 2)Study completedNCT00689442
What this trial is testing

Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

Who this might be right for
Dyslipidemia
Akros Pharma Inc. 105
Testing effectiveness (Phase 2)Study completedNCT01426438
What this trial is testing

Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 99
Not applicableStudy completedNCT02322203
What this trial is testing

Effects of Niacin Therapy on Lipoprotein Composition and Function

Who this might be right for
Cardiovascular Disease
National Heart, Lung, and Blood Institute (NHLBI) 22
Not applicableStudy completedNCT04100356
What this trial is testing

The Effect of Exercise and/or Diet on Health Related Parameters

Who this might be right for
Overweight and Obesity
Atlantis Medical University College 57
Not applicableStudy completedNCT01690312
What this trial is testing

Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy

Who this might be right for
Cardiovascular Disease
Nutrasource Pharmaceutical and Nutraceutical Services, Inc. 36
Not applicableStudy completedNCT01101230
What this trial is testing

Effects of Almonds on Cardiovascular Risk Factors

Who this might be right for
Cardiovascular Disease
Penn State University 61
Large-scale testing (Phase 3)Study completedNCT04998981
What this trial is testing

Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C

Who this might be right for
Hyperlipidemia
Kowa Company, Ltd. 353
Not applicableNot Yet RecruitingNCT07515573
What this trial is testing

Effect of Compound (Cardiol Forte) on Lipid And Glycemic Parameters in Low Cardiovascular Risk Individuals

Who this might be right for
Dyslipidemia
U.G.A. Nutraceuticals 50
Testing effectiveness (Phase 2)Study completedNCT00169559
What this trial is testing

Dyslipidemia Study Investigating The Increase In "Good Cholesterol"

Who this might be right for
Dyslipidaemias
GlaxoSmithKline 250
Not applicableStudy completedNCT00006295
What this trial is testing

Molecular & Clinical Evaluation of Low HDL Syndromes

Who this might be right for
Cardiovascular DiseasesHeart DiseasesAtherosclerosis
University of Maryland, Baltimore 370
Large-scale testing (Phase 3)WithdrawnNCT01972477
What this trial is testing

DLBS1449 in Diabetic Patients With Low HDL

Who this might be right for
Diabetic PatientsLow HDL-cholesterol (< 35 mg/dL)Lifestyle Intervention for at Least 1 Month
Dexa Medica Group
Large-scale testing (Phase 3)Ended earlyNCT02697136
What this trial is testing

CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases

Who this might be right for
Familial Hypoalphalipoproteinemia
Cerenis Therapeutics, SA 30
Large-scale testing (Phase 3)Ended earlyNCT01335997
What this trial is testing

Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143)

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,139
Not applicableStudy completedNCT01889368
What this trial is testing

Effect of a Grape Seed Extract (GSE) on Insulin Resistance

Who this might be right for
Metabolic Syndrome
University of California, Davis 19
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation